Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

NHS National Framework for Transition products commencing 1 October 2024

NHS England

This public procurement record has 2 releases in its history.

Award

17 Oct 2024 at 16:47

Award Notice
Tender

26 Jun 2024 at 14:59

Tender Notice
Summary of the contracting process

The NHS National Framework for Transition products, managed by NHS England, involves the procurement of pharmaceutical products under an open procedure. This framework, set to commence on 1 October 2024 and potentially extendable up to 24 months, comprises two main lots - CM/TNS/24/5712/01 (including products like Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection, and rivaroxaban tablets) and CM/TNS/24/5712/02 (Imatinib). The procurement is valued at approximately £131 million and spans different UK regions such as CESW, NWLN, LSNE, and DSW, with contracts signed to commence and conclude within specific dates through to 2026. Contract awardees, including large and SME suppliers, have been confirmed for various products.

This tender offers significant opportunities for pharmaceutical companies to expand their market presence within the NHS framework. Businesses that can supply the specified pharmaceutical products at competitive prices will benefit from involvement in this high-value procurement process, contributing to the delivery of healthcare services across the UK. Both large corporations and SMEs have been awarded contracts, indicating that vendors of various scales can successfully compete and potentially secure substantial, long-term supply agreements with NHS England under this national framework. The procurement process is conducted electronically, ensuring streamlined communication and submission procedures.

How relevant is this notice?

Notice Information

Notice Title

NHS National Framework for Transition products commencing 1 October 2024

Notice Description

Project title: NHS National Framework for Transition products commencing 1 October 2024<br/>Offer reference number: CM/TNS/24/5712<br/>Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months.<br/>Potential periods of call-offs under the framework agreement:<br/> <br/>CM/TNS/24/5712/01 - Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tablets<br/>Lot 1 CESW: 01/10/2024 to 30/09/2025 (12 months) <br/>Lot 2 NWLN: 01/10/2024 to 30/09/2025 (12 months) <br/>Lot 3 LSNE: 01/10/2024 to 31/05/2026 (20 months) <br/><br/>CM/TNS/24/5712/02 - Imatinib<br/>Lot 1 DSW: 01/10/2024 to 30/09/2025 (12 months) <br/><br/>Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England

Lot Information

CM/TNS/24/5712/01

CM/TNS/24/5712/01 - Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tablets
Lot 1 CESW: 01/10/2024 to 30/09/2025 (12 months)
Lot 2 NWLN: 01/10/2024 to 30/09/2025 (12 months)
Lot 3 LSNE: 01/10/2024 to 31/05/2026 (20 months) Additional information: CM/TNS/24/5712/01 - Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tablets
Lot 1 CESW: 01/10/2024 to 30/09/2025 (12 months)
Lot 2 NWLN: 01/10/2024 to 30/09/2025 (12 months)
Lot 3 LSNE: 01/10/2024 to 31/05/2026 (20 months)

Options: Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months

CM/TNS/24/5712/02

CM/TNS/24/5712/02 - Imatinib
Lot 1 DSW: 01/10/2024 to 30/09/2025 (12 months) Additional information: CM/TNS/24/5712/02 - Imatinib
Lot 1 DSW: 01/10/2024 to 30/09/2025 (12 months)

Options: Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-0472c3
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/033646-2024
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
Tender Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
Not specified
Awardee Scale
Large, SME

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£131,960,000 £100M-£1B
Lots Value
£131,960,000 £100M-£1B
Awards Value
Not specified
Contracts Value
£1

Notice Dates

Publication Date
17 Oct 20241 years ago
Submission Deadline
29 Jul 2024Expired
Future Notice Date
Not specified
Award Date
30 Sep 20241 years ago
Contract Period
1 Oct 2024 - 30 Sep 2025 6-12 months
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Cancelled
Awards Status
Active
Contracts Status
Active

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
NHS England
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
LEEDS
Postcode
LS1 4AP
Postcode Area
Leeds
Country
England
Major Region (ITL 1)
TLE Yorkshire and The Humber
Basic Region (ITL 2)
TLE4 West Yorkshire
Small Region (ITL 3)
TLE42 Leeds
Delivery Location
Not specified
Local Authority
Leeds
Electoral Ward
Hunslet & Riverside
Westminster Constituency
Leeds South

Supplier Information

Number of Suppliers
12
Supplier Names

Accord-UK Ltd

Amarox Limited

Celix Pharma Ltd.

Dr.Reddy's Laboratories (UK) Limited

Gilead Sciences Limited

Glenmark Pharmaceuticals Europe Limited

Mercury Pharmaceuticals Limited

Seacross Pharmaceuticals Ltd

Teva UK Limited

Thornton and Ross Ltd

Tillomed Laboratories ltd

Zentiva Pharma UK Ltd

Further Information

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...